For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/BRK865. CME/MOC/NCPD/AAPA credit will be available until April 29, 2026.
Exploring the Promise of Biomarkers and ATTs in Diagnosing and Treating Early Symptomatic Alzheimer’s Disease: Key Takeaways From AD/PD 2025 and AAN 2025
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Lilly.
Disclosure information is available at the beginning of the video presentation
View all episodes
By PVI, PeerView Institute for Medical Education
3.5
2727 ratings
For the full presentation, downloadable slides, and complete CME/MOC/NCPD/AAPA information, and to apply for credit, please visit us at PeerView.com/BRK865. CME/MOC/NCPD/AAPA credit will be available until April 29, 2026.
Exploring the Promise of Biomarkers and ATTs in Diagnosing and Treating Early Symptomatic Alzheimer’s Disease: Key Takeaways From AD/PD 2025 and AAN 2025
In support of improving patient care, PVI, PeerView Institute for Medical Education, is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.
Support
This activity is supported by an educational grant from Lilly.
Disclosure information is available at the beginning of the video presentation
130 Listeners
5 Listeners
3 Listeners
3 Listeners
10 Listeners
5 Listeners
9 Listeners
3 Listeners
2 Listeners
5 Listeners
3 Listeners
3 Listeners
5 Listeners
5 Listeners
2 Listeners
0 Listeners
9 Listeners
1,865 Listeners
536 Listeners
2 Listeners
962 Listeners
11 Listeners
2 Listeners
480 Listeners
680 Listeners
281 Listeners
255 Listeners
3,340 Listeners
88 Listeners
1,097 Listeners
180 Listeners
509 Listeners
242 Listeners
362 Listeners